Adial Pharmaceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $49.53K, a 37.43% decline year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $427.32K, a 9.83% decline year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $62.13K, a 85.08% decline year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2022-09-30 was $79.15K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2025 was $367.75K, a 84.45% increase from fiscal 2024.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2024 was $199.38K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2021 was $1.98M, a 178.69% increase from fiscal 2020.
- Adial Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2020 was $710.79K, a 35.71% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $367.75K 10-K · filed 2026-03-05 | |
| 2024-12-31 | $199.38K 10-K · filed 2026-03-05 | |
| 2023-09-30 | $49.53K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $427.32K 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $62.13K 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $79.15K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $473.91K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $416.42K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $1.98M 10-K · filed 2022-03-28 | |
| 2020-12-31 | $710.79K 10-K · filed 2022-03-28 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $523.75K derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | $581.88K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$58.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $523.75K 10-K · filed 2021-03-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |